Anti-trypanosomal activity and target validation of the M17 leucyl-aminopeptidase inhibitor DDD00057570 in Trypanosoma cruzi
A compound originally designed to block the same enzyme in the related parasite causing leishmaniasis is found that it blocks the recombinant enzyme, slows the proliferation of the parasite, and reduces the number of parasites bursting from infected mammalian cells, the step by which infection spreads through the body.